Oramed Pharmaceuticals (ORMP) Other Non-Current Liabilities (2011 - 2024)
Oramed Pharmaceuticals (ORMP) reported Other Non-Current Liabilities of $60000.0 for Q4 2024, down 4.76% on a YoY basis from $63000.0 in Q1 2024, and little changed quarter-over-quarter from $60000.0 in Q3 2024.
Oramed Pharmaceuticals (ORMP) Other Non-Current Liabilities (2011 - 2024) Analysis & Trends
Oramed Pharmaceuticals has reported Other Non-Current Liabilities for 14 years, with the latest figure at $60000.0 in Q4 2024.
- For the quarter ending Q4 2024, Other Non-Current Liabilities fell 4.76% year-over-year to $60000.0; the trailing twelve-month figure through Dec 2024 stood at $60000.0 (down 4.76% YoY), and the FY2024 full-year result was $60000.0, down 4.76% from the prior year.
- Other Non-Current Liabilities for Q4 2024 stood at $60000.0, roughly flat from $60000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $6.9 million in Q3 2020, with the low at $11000.0 in Q2 2020.
- Historically, Other Non-Current Liabilities has averaged $427850.0 across 5 years, with a median of $62000.0 in 2022.
- Annual changes were most pronounced in 2020 — Other Non-Current Liabilities jumped 63054.55% — and 2021, when it sank 98.22%.
- Oramed Pharmaceuticals' Other Non-Current Liabilities stood at $11000.0 in 2020, then jumped by 1009.09% to $122000.0 in 2021, then slumped by 50.0% to $61000.0 in 2022, then advanced by 3.28% to $63000.0 in 2023, then slipped by 4.76% to $60000.0 in 2024.
- The last three Other Non-Current Liabilities figures came in at $60000.0 (Q4 2024), $60000.0 (Q3 2024), and $60000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Oramed Pharmaceuticals | 151.47 Mn | 133.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 60,000.00 |
| Sep 30, 2024 | 60,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Mar 31, 2024 | 63,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | 66,000.00 |
| Mar 31, 2023 | 59,000.00 |
| Dec 31, 2022 | 61,000.00 |
| Sep 30, 2022 | 61,000.00 |
| Jun 30, 2022 | 60,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Nov 30, 2021 | 122,000.00 |
| Aug 31, 2021 | 124,000.00 |
| May 31, 2021 | 160,000.00 |
| Feb 28, 2021 | 177,000.00 |
| Nov 30, 2020 | 11,000.00 |
| Aug 31, 2020 | 6.95 Mn |
| May 31, 2020 | 11,000.00 |
| Feb 29, 2020 | 232,000.00 |